New device aims to grow gut length for short bowel patients

NCT ID NCT05535361

Recruiting now Disease control Sponsor: Eclipse Regenesis, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 2 times

Summary

This study tests a device called the Eclipse XL1 that is placed inside the body to slowly stretch and lengthen the remaining small intestine in people with short bowel syndrome. The goal is to improve nutrition and reduce the need for intravenous feeding. The study will enroll 40 children and adults aged 3 months to 65 years who have at least 3 cm of bowel left. Researchers will monitor safety and measure how much the intestine grows.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SHORT BOWEL SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

intestinal atresia Intestinal Failure intestinal volvulus necrotizing enterocolitis short bowel syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SHORT BOWEL SYNDROME

Contacts and locations

Locations

Boston Children's Hospital
RECRUITING

Boston, Massachusetts, 02115, United States
Children's National Hospital
RECRUITING

Washington D.C., District of Columbia, 20010, United States
Cincinnati Children's Hospital
RECRUITING

Cincinnati, Ohio, 45229-3026, United States
Lucile Packard Children's Hospital Stanford
RECRUITING

Palo Alto, California, 94303, United States
University of California San Francisco
RECRUITING

San Francisco, California, 94143, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.